Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PulseAI has developed a cloud-based AI software platform trained on over 6 million ECGs from 2 million patients to improve the accuracy and scalability of cardiac diagnostics. The company recently entered a strategic collaboration with Trinity Biotech to apply its expertise in medical sensor data and machine learning to continuous glucose monitoring (CGM) analytics. Clinical results are not detailed publicly but the company’s technology has been validated through large-scale dataset training and academic collaborations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PulseAI.